Key points are not available for this paper at this time.
The prognostic score we developed may be useful in designing clinical trials for the treatment of advanced Hodgkin's disease and in making individual therapeutic decisions, but a distinct group of patients at very high risk could not be identified on the basis of routinely documented demographic and clinical characteristics.
Building similarity graph...
Analyzing shared references across papers
Loading...
Dirk Hasenclever
Leipzig University
Volker Diehl
Andrews University
Jamés O. Armitage
Northwestern University
New England Journal of Medicine
University of Cologne
Leipzig University
Building similarity graph...
Analyzing shared references across papers
Loading...
Hasenclever et al. (Thu,) studied this question.
synapsesocial.com/papers/69d960fc7fca1f84ab684df0 — DOI: https://doi.org/10.1056/nejm199811193392104